1 terminated. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Terminated 1 |
Follow PEGPH20: new trials by email Literature Review of PEGPH20 trials Research Report on PEGPH20
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of PEGPH20 in Combination With Avelumab in Chemotherapy Resistant Pancreatic Cancer PEGylated Recombinant Human Hyaluronidase (PEGPH20), Avelumab - Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer | Early Phase 1 | Terminated | PH Research, S.L. | 7 | 2018-01-10 | 2019-08-22 |
Spain (1)